BMY-43748 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It has been investigated for its potential role as an inhibitor of specific enzymes or pathways that are crucial for the survival and proliferation of cancer cells. Researchers have explored its efficacy in preclinical models to assess its ability to halt tumor growth or induce apoptosis in malignant cells. Additionally, BMY-43748 has been studied in combination with other therapeutic agents to evaluate synergistic effects, which could enhance the overall treatment outcomes for certain types of cancers. Its application is largely confined to experimental and developmental stages, with ongoing studies aimed at understanding its full potential and safety profile.